Tissue factor pathway inhibitor, vascular risk factors and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis

Atherosclerosis

Volumn 207, Issue 1, 2009, Pages 277-283

  Mitchell, C T ^a   Kamineni, A ^b   Palmas, W ^c   Cushman, M ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Atherosclerosis; Coronary heart disease; Risk factor; Tissue factor pathway inhibitor

Indexed keywords

CALCIUM; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CORONARY ARTERY; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING;

AGED; AGED, 80 AND OVER; ANKLE; BIOLOGICAL MARKERS; BLOOD PRESSURE; BRACHIAL ARTERY; CALCIUM; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CORONARY ARTERY DISEASE; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FEMALE; HUMANS; LINEAR MODELS; LIPOPROTEINS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TUNICA INTIMA; TUNICA MEDIA; UNITED STATES; UP-REGULATION;

EID: 70350764589     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.04.024     Document Type: Article

References (24)

1. Kato H. Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects. Arterioscler Thromb Vasc Biol 22 (2002) 539-548
2. Drew A.F., Davenport P., Apostolopoulos J., and Tipping P.G. Tissue factor pathway inhibitor expression in atherosclerosis. Lab Invest 77 (1997) 291-298
3. Caplice N.M., Mueske C.S., Kleppe L.S., and Simari R.D. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity. Circulation 98 (1998) 1051-1057
4. Crawley J., Lupu F., Westmuckett A.D., Severs N.J., Kakkar V.V., and Lupu C. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol 20 (2000) 1362-1373
5. Jang Y., Guzman L.A., Lincoff A.M., et al. Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model. Circulation 92 (1995) 3041-3050
6. Asada Y., Hara S., Tsuneyoshi A., et al. Fibrin-rich and platelet-rich thrombus formation on neointima: recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following repeated balloon injury of rabbit aorta. Thromb Haemost 80 (1998) 506-511
7. Yin X., Yutani C., Ikeda Y., et al. Tissue factor pathway inhibitor gene delivery using HVJ-AVE liposomes markedly reduces restenosis in atherosclerotic arteries. Cardiovasc Res 56 (2002) 454-463
8. Westrick R.J., Bodary P.F., Xu Z., Shen Y.C., Broze G.J., and Eitzman D.T. Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice. Circulation 103 (2001) 3044-3046
9. Kokawa T., Enjyoji K., Kumeda K., et al. Measurement of the free form of TFPI antigen in hyperlipidemia. Relationship between free and endothelial cell-associated forms of TFPI. Arterioscler Thromb Vasc Biol 16 (1996) 802-808
10. Morange P.E., Renucci J.F., Charles M.A., et al. Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers. Thromb Haemost 85 (2001) 999-1003
11. Soejima H., Ogawa H., Yasue H., et al. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. Circulation 99 (1999) 2908-2913
12. Novo G., Caplice N., Tantillo R., Bonura F., Simari R., and Novo S. TFPI antigen and activity levels in patients with asymptomatic atherosclerosis and target organ acute and chronic complications. Int Angiol 24 (2005) 366-371
13. Blann A.D., Amiral J., McCollum C.N., and Lip G.Y. Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls. Atherosclerosis 152 (2000) 29-34
14. Morange P.E., Simon C., Alessi M.C., et al. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation 109 (2004) 1343-1348
15. Morange P.E., Blankenberg S., Alessi M.C., et al. Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study. J Thromb Haemost 5 (2007) 475-482
16. Sakkinen P.A., Cushman M., Psaty B.M., et al. Correlates of antithrombin, protein C, protein S, and TFPI in a healthy elderly cohort. Thromb Haemost 80 (1998) 134-139
17. Sakata T., Mannami T., Baba S., et al. Potential of free-form TFPI and PAI-1 to be useful markers of early atherosclerosis in a Japanese general population (the Suita Study): association with the intimal-medial thickness of carotid arteries. Atherosclerosis 176 (2004) 355-360
18. Bild D.E., Bluemke D.A., Burke G.L., et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156 (2002) 871-881
19. Carr J.J., Nelson J.C., Wong N.D., et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 234 (2005) 35-43
20. Greenland P., Bonow R.O., Brundage B.H., et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation 115 (2007) 402-426
21. Sharrett A.R., Ding J., Criqui M.H., et al. Smoking, diabetes, and blood cholesterol differ in their associations with subclinical atherosclerosis: the Multiethnic Study of Atherosclerosis (MESA). Atherosclerosis 186 (2006) 441-447
22. Dahm A.E., Andersen T.O., Rosendaal F., and Sandset P.M. A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI). J Thromb Haemost 3 (2005) 651-658
23. Lwaleed B.A., and Bass P.S. Tissue factor pathway inhibitor: structure, biology and involvement in disease. J Pathol 208 (2006) 327-339
24. Lutsey P.L., Cushman M., Steffen L.M., et al. Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. J Thromb Haemost 4 (2006) 2629-2635